ctrl K

Price Alert

Heart Test Laboratories I... (HSCS)

NASDAQ: HSCS · Real-Time Price · USD

3.39

-0.11 (-3.14%)

At close: Aug 15, 2025, 12:48 PM

Heart Test Laboratories Income Statement

Financials in USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Revenue	4.35K	18.6K	5.15K	14.37K	25.6K
Cost of Revenue	1.88K	6.08K	2.8K	7.89K	10.66K
Gross Profit	2.47K	12.52K	2.35K	6.48K	14.94K
Operating Income	-8.35M	-6.31M	-6.11M	-4.71M	-2.57M
Interest Income	n/a	n/a	n/a	n/a	n/a
Pretax Income	-8.77M	-6.61M	-6.35M	-4.83M	-2.45M
Net Income	-8.77M	-6.61M	-490.85M	-4.58M	-2.58M
Selling & General & Admin	3.97M	3.44M	3.65M	1.71M	874.62K
Research & Development	4.39M	2.88M	2.46M	3M	1.71M
Other Expenses	n/a	n/a	1.85K	2.56K	-3.45K
Operating Expenses	8.36M	6.32M	6.12M	4.72M	2.58M
Interest Expense	500.45K	354.08K	243.17K	371.62K	132.45K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	8.36M	6.32M	6.12M	4.72M	2.59M
Income Tax Expense	n/a	n/a	484.5M	-250.2K	129K
Shares Outstanding (Basic)	938.26K	352.52K	79.5K	33.19K	33.14K
Shares Outstanding (Diluted)	938.26K	352.52K	79.5K	33.19K	33.14K
EPS (Basic)	-9.34	-18.74	-6.17K	-137.94	-77.89
EPS (Diluted)	-9.34	-18.74	-6.17K	-137.94	-77.89
EBITDA	-8.14M	-6.16M	-6.08M	-4.43M	-2.29M
EBIT	-8.26M	-6.25M	-6.11M	-4.46M	-2.32M
Depreciation & Amortization	127.96K	95.13K	26.91K	26.57K	33.61K